Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age.
Anvisa said it approved the measure after seeing studies, conducted outside Brazil, that showed safety and efficacy for the age group.
The vaccine, the first in Brazil to receive definitive approval from Anvisa, was already authorized for use on adolescents aged 16 and over, the regulator said. It added that the Pfizer vaccine was currently the only one authorized to be used on minors.Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Myocarditis from Pfizer, Moderna COVID-19 vaccines: What to knowYoung people are experiencing rare cases of heart inflammation after getting coronavirus vaccines, but doctors say the risk of COVID-19 is far greater
Read more »
U.S. to buy 500 million Pfizer Covid vaccines to share globally, source saysThe U.S. will buy 500M more doses of the Pfizer vaccine to share with 92 lower-income countries and the African Union over the next year. megtirrell has the details.
Read more »
US to donate 500 million doses of Pfizer vaccine to the world; India surge eases: Live COVID-19 updatesThe Biden administration will purchase 500 million doses of the Pfizer vaccine and donate it globally, Latest COVID-19 news.
Read more »
Brazil Gets Green Light To Host Massive Soccer Tournament Despite Coronavirus RisksI am a Texas native covering breaking news out of New York City. Previously, I was an editorial assistant at the Forbes London bureau.
Read more »
Brazil miner Samarco offers creditors shares or 85% haircut - sourcesSamarco Mineracao SA, a bankrupt joint venture between Brazilian miner Vale SA (VALE3.SA) and BHP Group Ltd (BHP.AX), proposed on Thursday a plan to restructure 50 billion reais ($10 billion) in debt with an offer of preferred shares or a cash payout in 2041 equal to 15% of the current value of holdings, sources said.
Read more »
Sinovac CEO complained about anti-China comments in Brazil -sourcesThe chief executive of Sinovac Biotech Ltd (SVA.O), the main supplier of COVID-19 vaccines to Brazil, complained last month to Brazilian diplomats in Beijing that anti-China comments in Brasilia were not helping with delayed shipments, two people with knowledge of the matter told Reuters.
Read more »